Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases

Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide–Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia

(2011) Joseph Cheriyan et al.   CIRCULATION

An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease

(2011) David A. Lomas et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies

(2010) Shuying Yang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The p38α Kinase Plays a Central Role In Inflammation

(2009) Gary Schieven   CURRENT TOPICS IN MEDICINAL CHEMISTRY

p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression

(2009) Nicola M. Aston et al.   JOURNAL OF MEDICINAL CHEMISTRY

Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders

(2009) David M. Goldstein et al.   JOURNAL OF MEDICINAL CHEMISTRY

Evaluation of different tests based on observations for external model evaluation of population analyses

(2009) Karl Brendel et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Sample-size calculations for multi-group comparison in population pharmacokinetic experiments

(2009) Kayode Ogungbenro et al.   PHARMACEUTICAL STATISTICS

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

(2008) Emmanuelle Comets et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Application of optimal design methodologies in clinical pharmacology experiments

(2008) Kayode Ogungbenro et al.   PHARMACEUTICAL STATISTICS